MRC Call for Applications: Infections and Immunity research grant
Funding is available from the Medical Research Council’s (MRC) Infections and Immunity Board to support focused research projects on infections and immunity. MRC will award research grants to UK-based research organisations, but research grants may involve more than one research group or institution. There is no limit to the funding you can request, but it should be appropriate to the project, typically awards are up to £1 million. We will usually fund up to 80% of your project’s full economic cost. Projects can last up to five years and are typically three to four years.
Eligibility:
Any UK-based researcher with an employment contract at an eligible research organisation can apply. You will need to:
- have at least a graduate degree, although we usually expect most applicants to have a PhD or medical degree
- show that you will direct the project and be actively engaged in the work.
You can include one or more industry partners as project partners in your application. International co-investigators can be included if they provide expertise not available in the UK.
Research included:
- discovery research relating to human pathogens, pathogenicity, antimicrobial resistance, host pathogen responses including inflammation and the development function and disorders of the immune system where this informs mechanism of disease. Immune disease including allergy (except asthma and other organ-based disorders), transplantation immunology, systemic immune disorders and auto-immune disease. Including use of in silico systems, relevant animal models and experimental studies in humans throughout the lifecourse
- population-level research, using epidemiological, genetic and ‘omic approaches, and computational modelling, to elucidate disease risks, aetiologies and progression, and to understand the evolution of pathogen populations and epidemic preparedness
- research to inform novel strategies for preventing and controlling infectious and immune disease, including vector control, predictive modelling and early development research to inform future intervention strategies including vaccines.
Read more here.
Application deadline May 12, 2021.
